BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30371119)

  • 1. The association between the red cell distribution width and diabetic nephropathy in patients with type-2 diabetes mellitus.
    Zhang J; Zhang R; Wang Y; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
    Ren Fail; 2018 Nov; 40(1):590-596. PubMed ID: 30371119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
    Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
    Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients.
    Zhao L; Zou Y; Zhang J; Zhang R; Ren H; Li L; Guo R; Zhang J; Liu F
    Int J Med Sci; 2020; 17(14):2113-2124. PubMed ID: 32922172
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
    BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
    Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression.
    Zhang J; Xiao X; Wu Y; Yang J; Zou Y; Zhao Y; Yang Q; Liu F
    Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of immunoglobulin G deposit in glomeruli in Chinese patients with diabetic nephropathy.
    Zhang J; Zhang J; Zhang R; Wang Y; Liang Y; Yang Z; Wang T; Xu X; Liu F
    J Diabetes; 2020 Jul; 12(7):521-531. PubMed ID: 32031751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
    Zhao L; Ren H; Zhang R; Wang T; Zou Y; Xu H; Li L; Cooper ME; Liu F
    Int Urol Nephrol; 2021 Jun; 53(6):1161-1170. PubMed ID: 33389518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy.
    Zhuo L; Zhang N; Zou G; Chen D; Li W
    Front Med; 2017 Sep; 11(3):386-392. PubMed ID: 28871455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
    Zhao L; Zhang Y; Liu F; Yang H; Zhong Y; Wang Y; Li S; Su Q; Tang L; Bai L; Ren H; Zou Y; Wang S; Zheng S; Xu H; Li L; Zhang J; Chai Z; Cooper ME; Tong N
    J Endocrinol Invest; 2021 Dec; 44(12):2709-2723. PubMed ID: 34043214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal histologic changes and the outcome in patients with diabetic nephropathy.
    An Y; Xu F; Le W; Ge Y; Zhou M; Chen H; Zeng C; Zhang H; Liu Z
    Nephrol Dial Transplant; 2015 Feb; 30(2):257-66. PubMed ID: 25063425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study.
    Yu Y; Zhu C; Lin Y; Qian Q; Shen X; Zou W; Wang M; Gong J; Chen M; Liu L; Yu R; Shen Q; Shao L; Zhu B
    Ren Fail; 2023; 45(2):2285868. PubMed ID: 38013428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
    J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy.
    Zhang J; Zhang R; Wang Y; Li H; Han Q; Wu Y; Wang T; Liu F
    J Diabetes Res; 2019; 2019():7825804. PubMed ID: 30911552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy.
    Zhang J; Wang Y; Gurung P; Wang T; Li L; Zhang R; Li H; Guo R; Han Q; Zhang J; Lei S; Liu F
    Acta Diabetol; 2018 Jul; 55(7):669-679. PubMed ID: 29610978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
    Diabetes Res Clin Pract; 2018 Jul; 141():1-9. PubMed ID: 29684616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease.
    Yonemoto S; Hamano T; Fujii N; Shimada K; Yamaguchi S; Matsumoto A; Kubota K; Hashimoto N; Oka T; Senda M; Sakaguchi Y; Matsui I; Isaka Y
    PLoS One; 2018; 13(6):e0198825. PubMed ID: 29889895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.